Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Less Cost at the Expense of More Genitourinary Toxicity Is a Concerning But Testable Hypothesis-Reference-Cited by-同舟云学术

Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Less Cost at the Expense of More Genitourinary Toxicity Is a Concerning But Testable Hypothesis

Published:2014-04-20 Issue:12 Volume:32 Page:1183-1185
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

D'Amico Anthony V.¹

Affiliation:

1. Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2014.55.2380

Reference22 articles.

1. Screening and Prostate-Cancer Mortality in a Randomized European Study

2. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

3. Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial

4. Current recommendation 2012 US Preventative Services Task Force: Screening for prostate cancer http://www.uspreventiveservicestaskforce.org/prostatecancerscreening.htm

5. Radical Prostatectomy versus Observation for Localized Prostate Cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extreme hypofractionated stereotactic radiotherapy for localized prostate Cancer: Efficacy and late urinary toxicity according to transurethral resection of the prostate history;Clinical and Translational Radiation Oncology;2024-05

2. A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancer;Radiotherapy and Oncology;2022-06

3. Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer;JAMA Oncology;2021-05-01

4. Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer;JAMA Network Open;2019-02-08

5. Bases référentielles de la radiothérapie en conditions stéréotaxiques pour les tumeurs ou métastases bronchopulmonaires, hépatiques, prostatiques, des voies aérodigestives supérieures, cérébrales et osseuses;Cancer/Radiothérapie;2018-10